Essential medicines and health products

Developing an approach for using health technology assessments in reimbursement systems for medical products

Geneva, Switzerland July 20-21, 2015

Authors:
WHO

Publication details

Number of pages: 29
Publication date: October 2015
Languages: English
WHO reference number:
WHO/EMP/PAU/2015.5

Downloads

A two day meeting was held to discuss the use of health technology assessment (HTA) in low and middle income countries (LMIC), including aspects of its use in relation to medicine and health technologies, pricing policies and reimbursement decisions. The meeting brought together experts in HTA and pharmaceutical economics from academia; WHO regional advisors from Europe (EURO), Africa (AFRO), Eastern Mediterranean (EMRO) and the Americas (PAHO), as well as representatives from LMIC that have started using elements of HTA, or are working towards doing so. (Annex 1). In addition, the meeting discussed possible follow-up actions, including a proposed larger consultation to be held late in 2015. A key discussion point was to identify the future role for WHO in supporting the development of HTA, particularly given the WHA resolution from 2014 (67.23) on the topic that called on WHO to develop global guidance on methods and processes for health intervention and technology assessment in support of universal health coverage.